Residues In Transmembrane Domains Research Articles

T Cell Epitope 119-132, but Not 35-55, Is the Immunodominant Encephalitogenic Determinant of the CNS Autoantigen, Myelin Oligodendrocyte Glycoprotein (P05.118)

Objective: To evaluate native full-length MOG for novel T cell epitopes. Background Amino acid (aa) residues 35-55 within the extracellular domain 1-117 of myelin oligodendrocyte glycoprotein (MOG) contain its only known encephalitogenic T cell determinant for C57BL/6 (H-2^b) mice, a strain frequently studied in the multiple sclerosis (MS) model, experimental autoimmune encephalomyelitis (EAE). Based upon studies showing that processing of native MOG is required for presentation of 35-55, we predicted that MOG contains additional T cell epitopes. Design/Methods: C57BL/6 mice were immunized with full-length (218 aa) murine (self) MOG or overlapping peptides encompassing its entire sequence in complete Freund9s adjuvant. Proliferation was measured by 3^H-thymidine incorporation. ELISPOT was used to measure frequency of epitope-specific IFN-γ-producing T cells that were generated by in vivo priming with full-length MOG. Results: Three novel T cell epitopes were discovered, an encephalitogenic determinant within transmembrane domain residues 119-132, and two discrete nonencephalitogenic determinants, p181-195 and p186-200, in the cytoplasmic domain. Clinical EAE, CNS inflammation and demyelination induced by p119-132 were equal, or greater, in severity than with p35-55. T cell recognition of MOG p119-132 was restricted by MHC II (I-A^b) molecules and p119-132 induced EAE in other H-2^b strains, but not in mice of other haplotypes. MOG p119-132-primed T cells, which produced higher levels of pathogenic Th1 and Th17 cytokines than p35-55-primed T cells, adoptively transferred EAE to naive recipients. Frequency of T cells that responded to p119-132 after immunization with full-length MOG was greater than to p35-55 or the non-encephalitogenic determinants, demonstrating that p119-132 is the immunodominant determinant. Conclusions: MOG p119-132, not p35-55, is the immunodominant encephalitogenic determinant of MOG. Not all T cell epitopes of a self antigen are pathogenic. Recognizing that MOG contains multiple encephalitogenic and non-encephalitogenic determinants permits testing tolerogenic approaches that target individual non-pathogenic or pathogenic T cell epitopes. Supported by: NIH and Boehringer-Ingelheim. Disclosure: Dr. Shetty has received research support from Boehringer Ingelheim. Dr. Gupta has received research support from Boehringer Ingelheim Pharmaceuticals, Inc. Dr. Weber has received personal compensation for activities with Hoffmann-LaRoche, Genentech, Inc., Novartis, Bayer Pharmaceuticals Corporation, Merck Serono, Biogen Idec and Teva Neuroscience as a speaker and/or participant on an advisory board. Dr. Weber has received research support from Teva Neuroscience. Dr. Molnarfi has nothing to disclose. Dr. Forsthuber has received research support from the National Institutes of Health. Dr. Sobel has received research support from the NIH. Dr. Bernard has nothing to disclose. Dr. Slavin has received personal compensation for activities with Boehringer Ingelheim as an employee. Dr. Slavin holds stock and/or stock options in Boehringer Ingelheim. Dr. Slavin has received research support from Boehringer Ingelheim. Dr. Zamvil has received personal compensation for activities with Biogen Idec, Teva Neuroscience and EMD Serono-Pfizer. Dr. Zamvil has received research support from the National Institutes of Health, National Multiple Sclerosis Society, the Maisin Foundation, the Guthy Jackson Charitable Foundation, Teva Neuroscience, and Boehringer Ingelheim Pharmaceuticals, Inc.

Anion selectivity and counter‐ion cation permeation in glycine receptor‐channels

The polarity of the permeant ion (ion charge selectivity) is a major determinant of the physiological function of cys‐loop receptor‐channels at central synapses. Our studies aim to determine the molecular and biophysical basis of ion permeation in α1 glycine receptors (GlyRs) expressed in HEK‐293 cells, using patch clamp techniques. We previously reported a mutation to a critical M2 transmembrane domain residue (A251E) converts the channel from anion to cation selective, with the mean Cl− to Na+ permeability ratio (PCl/PNa) changing from 25.1 to 0.31. Mutations to neutralize or invert the charge of basic residues within an intracellular (“portals”) or extracellular (K104) component of the extended permeation pathway did not affect PCl/PNa, supporting the notion of a discrete ion charge selectivity filter at the internal end of the M2 delineated pore. With more precise consideration of liquid junction potentials (calculated using activities), the PCl/PNa in WT GlyRs is 11.8±0.4 (n=32) in the absence of divalent cations, and 16.2±0 (n=6) in 4 mM external Ca2+. PCl/PCs is even lower (5.0±0.5, n=6). A mutant anionic GlyR with a larger pore diameter (P250Δ) shows greater relative Na+ permeation. Hence counterion cations permeate through GlyRs, the relative extent of which depends on the pore size, the hydrated cation size and the presence of divalent cations. Funded by UNSW Faculty Research Grants.

The Accessibility in the External Part of the TM5 of the Glutamate Transporter EAAT1 Is Conformationally Sensitive during the Transport Cycle

BackgroundExcitatory amino acid transporter 1 (EAAT1) is a glutamate transporter which is a key element in the termination of the synaptic actions of glutamate. It serves to keep the extracellular glutamate concentration below neurotoxic level. However the functional significance and the change of accessibility of residues in transmembrane domain (TM) 5 of the EAAT1 are not clear yet.Methodology/Principal FindingsWe used cysteine mutagenesis with treatments with membrane-impermeable sulfhydryl reagent MTSET [(2-trimethylammonium) methanethiosulfonate] to investigate the change of accessibility of TM5. Cysteine mutants were introduced from position 291 to 300 of the cysteine-less version of EAAT1. We checked the activity and kinetic parameters of the mutants before and after treatments with MTSET, furthermore we analyzed the effect of the substrate and blocker on the inhibition of the cysteine mutants by MTSET. Inhibition of transport by MTSET was observed in the mutants L296C, I297C and G299C, while the activity of K300C got higher after exposure to MTSET. Vmax of L296C and G299C got lower while that of K300C got higher after treated by MTSET. The L296C, G299C, K300C single cysteine mutants showed a conformationally sensitive reactivity pattern. The sensitivity of L296C to MTSET was potentiated by glutamate and TBOA,but the sensitivity of G299C to MTSET was potentiated only by TBOA.Conclusions/SignificanceAll these facts suggest that the accessibility of some positions of the external part of the TM5 is conformationally sensitive during the transport cycle. Our results indicate that some residues of TM5 take part in the transport pathway during the transport cycle.

Basic amino-acid side chains regulate transmembrane integrin signalling

Side chains of Lys/Arg near transmembrane domain (TMD)1–3 membrane-water interfaces can “snorkel” placing their positive charge near negatively-charged phospholipid head groups4–6; however, snorkeling's functional effects are obscure. Integrin β TMDs exhibit such conserved basic amino acids; here we used nuclear magnetic resonance (NMR) spectroscopy7, 8 to show that integrin β3(Lys716) helps determine β3 TMD topography. The αIIbβ3 TMD structure suggests that precise β3 TMD crossing angles enable the assembly of outer and inner membrane “clasps” (OMC and IMC) that hold the αβ TMD together to limit transmembrane signalling9 . Mutation of β3(Lys716) caused dissociation of αIIbβ3 TMDs and integrin activation. To confirm that altered topography of β3(Lys716) mutants activated αIIbβ3, we utilized directed evolution of β3(K716A) to identify substitutions restoring default state. Introduction Pro(711) at the midpoint of β3 TMD (A711P) increased αIIbβ3 TMD association and inactivated integrin αIIbβ3(A711P,K716A). β3(Pro711) introduced a TMD kink of 30 ± 1° precisely at the OMC/IMC border, thereby decoupling the tilt between these segments. Thus, widely-occurring snorkeling residues in TMDs can help maintain TMD topography and membrane-embedding thereby regulating transmembrane signalling.

The Same Periplasmic ExbD Residues Mediate In Vivo Interactions between ExbD Homodimers and ExbD-TonB Heterodimers

The TonB system couples cytoplasmic membrane proton motive force to TonB-gated outer membrane transporters for active transport of nutrients into the periplasm. In Escherichia coli, cytoplasmic membrane proteins ExbB and ExbD promote conformational changes in TonB, which transmits this energy to the transporters. The only known energy-dependent interaction occurs between the periplasmic domains of TonB and ExbD. This study identified sites of in vivo homodimeric interactions within ExbD periplasmic domain residues 92 to 121. ExbD was active as a homodimer (ExbD(2)) but not through all Cys substitution sites, suggesting the existence of conformationally dynamic regions in the ExbD periplasmic domain. A subset of homodimeric interactions could not be modeled on the nuclear magnetic resonance (NMR) structure without significant distortion. Most importantly, the majority of ExbD Cys substitutions that mediated homodimer formation also mediated ExbD-TonB heterodimer formation with TonB A150C. Consistent with the implied competition, ExbD homodimer formation increased in the absence of TonB. Although ExbD D25 was not required for their formation, ExbD dimers interacted in vivo with ExbB. ExbD-TonB interactions required ExbD transmembrane domain residue D25. These results suggested a model where ExbD(2) assembled with ExbB undergoes a transmembrane domain-dependent transition and exchanges partners in localized homodimeric interfaces to form an ExbD(2)-TonB heterotrimer. The findings here were also consistent with our previous hypothesis that ExbD guides the conformation of the TonB periplasmic domain, which itself is conformationally dynamic.

In Situ Structural Characterization of a Recombinant Protein in Native Escherichia coli Membranes with Solid-State Magic-Angle-Spinning NMR

The feasibility of using solid-state magic-angle-spinning NMR spectroscopy for in situ structural characterization of the LR11 (sorLA) transmembrane domain (TM) in native Escherichia coli membranes is presented. LR11 interacts with the human amyloid precursor protein (APP), a central player in the pathology of Alzheimer's disease. The background signals from E. coli lipids and membrane proteins had only minor effects on the LR11 TM resonances. Approximately 50% of the LR11 TM residues were assigned by using (13)C PARIS data. These assignments allowed comparisons of the secondary structure of the LR11 TM in native membrane environments and commonly used membrane mimics (e.g., micelles). In situ spectroscopy bypasses several obstacles in the preparation of membrane proteins for structural analysis and offers the opportunity to investigate how membrane heterogeneity, bilayer asymmetry, chemical gradients, and macromolecular crowding affect the protein structure.

Taking the Escherichia coli TonB Transmembrane Domain “Offline”? Nonprotonatable Asn Substitutes Fully for TonB His20

The TonB system of Gram-negative bacteria uses the proton motive force (PMF) of the cytoplasmic membrane to energize active transport of nutrients across the outer membrane. The single transmembrane domain (TMD) anchor of TonB, the energy transducer, is essential. Within that TMD, His20 is the only TMD residue that is unable to withstand alanine replacement without a loss of activity. H20 is required for a PMF-dependent conformational change, suggesting that the importance of H20 lies in its ability to be reversibly protonated and deprotonated. Here all possible residues were substituted at position 20 (H20X substitutions). The His residue was also relocated throughout the TonB TMD. Surprisingly, Asn, a structurally similar but nonprotonatable residue, supported full activity at position 20; H20S was very weakly active. All the remaining substitutions, including H20K, H20R, H20E, and H20D, the obvious candidates to mimic a protonated state or support proton translocation, were inactive. A second-site suppressor, ExbB(A39E), indiscriminately reactivated the majority of H20 substitutions and relocations, including H20V, which cannot be made protonatable. These results suggested that the TonB TMD was not on a proton conductance pathway and thus only indirectly responds to PMF, probably via ExbD.

Truncated (N)-Methanocarba Nucleosides as A1 Adenosine Receptor Agonists and Partial Agonists: Overcoming Lack of a Recognition Element

A(1) adenosine receptor (AR) agonists are neuroprotective, cardioprotective, and anxiolytic. (N)-Methanocarba adenine nucleosides designed to bind to human A(1)AR were truncated to eliminate 5'-CH(2)OH. This modification previously converted A(3)AR agonists into antagonists, but the comparable effect at A(1)AR is unknown. In comparison to ribosides, affinity at the A(1)AR was less well preserved than at the A(3)AR, although a few derivatives were moderately A(1)AR selective, notably full agonist 21 (N(6)-dicyclopropylmethyl, K(i) 47.9 nM). Thus, at the A(1)AR recognition elements for nucleoside binding depend more on 5'region interactions, and in their absence A(3)AR selectivity predominates. Based on the recently reported agonist-bound AR structure, this difference between subtypes likely correlates with an essential His residue in transmembrane domain 6 of A(1) but not A(3)AR. The derivatives ranged from partial to full agonists in A(1)AR-mediated adenylate cyclase inhibition. Truncated derivatives have more drug-like physical properties than other A(1)AR agonists; this approach is appealing for preclinical development.

Molecular Dynamics of Proteorhodopsin in Lipid Bilayers by Solid-State NMR

Environmental factors such as temperature, hydration, and lipid bilayer properties are tightly coupled to the dynamics of membrane proteins. So far, site-resolved data visualizing the protein's response to alterations in these factors are rare, and conclusions had to be drawn from dynamic data averaged over the whole protein structure. In the current study, high-resolution solid-state NMR at high magnetic field was used to investigate their effects on the molecular dynamics of green proteorhodopsin, a bacterial light-driven proton pump. Through-space and through-bond correlation experiments were employed to identify and characterize highly mobile and motionally restricted regions of proteorhodopsin. Our data show that hydration water plays an essential role for enhancing molecular dynamics of residues in tails and interhelical loops, while it is found less important for residues in transmembrane domains or rigid, structured loop segments. In contrast, switching the lipids from the gel to their liquid crystalline phase enhances molecular fluctuations mainly in transmembrane helices on a time scale of 10(-6) s, but has little effect on loop and tail residues. Increased mobility is especially observed in helices C, F, and G, but also in the EF loop. Fluctuations in those regions are relevant to structural dynamics during the photocycle of proteorhodopsin. Our data are important for the functional understanding of proteorhodopsin, but also offer an important contribution to the general understanding of site-resolved effects of water and lipid bilayers onto the dynamic properties of membrane proteins.

Prediction and Verification of Critical Tension Sensing Residues in the E. coli Mechanosensitive Channel of Small Conductance (EC-MSCS)

We have previously used a combination of random mutagenesis and molecular dynamics simulations to identify and understand critical residues for tension sensation in MscL (mechanosensitive channel of large conductance) [Maurer et al JBC 2003, 278, 21076-21082; Elmore et. al Biophysical J., 2003, 85, 1512-1524]. In MscL, we were able to demonstrate a strong correlation between lipid-protein interaction energy, determined using a molecular dynamics simulation of the closed state structure, and mutant channel function. Upon mutation of amino acid residues in transmembrane domains that exhibited significant lipid interaction over the course of the simulation displayed were more likely than other transmembrane residues to display either a loss of function or a gain of function phenotype in bacterial assays. Here, we have employed a similar computational analysis to identify potentially critical lipid-binding residues for tension sensation in MscS. Molecular dynamics simulations of a closed state model of MscS were carried out in the presence of an explicit lipid membrane. Energetic analysis of lipid-protein interactions in the first transmembrane domain (TM1) and the second transmembrane domain (TM2) indicated ten residues (TM1: L35, I39, L42, I43, R46, N50, R54; and TM2: R74, L78, I82) with increased lipid interactions. Using site directed mutagenesis these residues were mutated to alanine and their ability to rescue MscL/MscS/MscK null E. coli from osmotic downshock was determined. Generally, mutating lipid interacting residues to alanine resulted in MscS channels that exhibited decreased ability to rescue bacteria from osmotic downshock, following a similar trend to our previous studies of MscL.

Functional Analysis of Transmembrane Domain 3 in NKCC1

We sought to determine the functional roles of residues in transmembrane domain (TM) 3 of human NKCC1 using tryptophan and cysteine scanning mutagenesis. We generated a structural alignment of the transmembrane domains of NKCC1 to the related APC transporters ApcT and AdiC, and obtained 3-D alignments using Modeller. Based on these alignments, residues 368 to 380 were predicted to form part of the inner 2/3 of the translocation pore. We substituted these residues with tryptophan and cysteine and determined the impact of the changes on protein synthesis and cell surface delivery by Western blotting and immunofluorescence microscopy. Most of our mutants expressed and localized similar to wild type NKCC1 and these were analyzed in depth for transporter function by means of Rb86 influx assays. A working hypothesis is that tryptophan mutants that are much reduced in function are too hydrophobic for the solvent interface and those residues that retain function are either protein interior or lipid facing. The pattern of the tryptophan scan followed an alpha helical periodicity. Based on the tryptophan scan we deduced that the non-functional mutants I368W, G369W, F372W, A375W, N376W, A379W are pore lining residues. Cysteine scanning complemented the results of the tryptophan scan. Since cysteine is a mild mutation, most mutants were functional. However I368C, G369C, A379C showed dramatic reduction or loss of function which suggested that either the cysteine was too large or disrupted substrate binding. Also F372C and N376C residues showed reduced chloride and rubidium affinity. The combined results of the two scanning approaches are consistent with our predictions of TM3 being an alpha helical domain with I368, G369, F372, A375, N376, A379 being pore lining residues.

Agonist activation of the G protein‐coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα13 and β‐arrestin‐2

GPR35 is a poorly characterized G protein-coupled receptor at which kynurenic acid has been suggested to be the endogenous ligand. We wished to test this and develop assays appropriate for the study of this receptor. Human and rat orthologues of GPR35 were engineered and expressed and assays developed to assess interaction with β-arrestin-2, activation of Gα₁₃ and agonist-induced internalization. GPR35-β-arrestin-2 interaction assays confirmed that both the endogenous tryptophan metabolite kynurenic acid and the synthetic ligand zaprinast had agonist action at each orthologue. Zaprinast was substantially more potent than kynurenic acid at each and both agonists displayed substantially greater potency at rat GPR35. Two novel thiazolidinediones also displayed agonism and displayed similar potency at each GPR35 orthologue. The three ligand classes acted orthosterically with respect to each other, suggesting overlapping binding sites and, consistent with this, mutation to alanine of the conserved arginine at position 3.36 or tyrosine 3.32 in transmembrane domain III abolished β-arrestin-2 recruitment in response to each ligand at each orthologue. These studies indicate that β-arrestin-2 interaction assays are highly appropriate to explore the pharmacology of GPR35 and that Gα₁₃ activation is an alternative avenue of signal generation from GPR35. Arginine and tyrosine residues in transmembrane domain III are integral to agonist recognition and function of this receptor. The potency of kynurenic acid at human GPR35 is sufficiently low, however, to question whether it is likely to be the true endogenous ligand for this receptor.

MzrA-EnvZ Interactions in the Periplasm Influence the EnvZ/OmpR Two-Component Regulon

MzrA was identified as a modulator of the EnvZ/OmpR two-component signal transduction system. Previous evidence indicated that MzrA interacts with EnvZ and modulates its enzymatic activities to influence OmpR phosphate (OmpR∼P) levels. Moreover, MzrA was shown to connect the bacterial envelope stress response systems CpxA/CpxR and σ(E) to EnvZ/OmpR to widen the defensive response regulatory network. In this study, experiments were carried out to establish whether the membrane or periplasmic domain of MzrA is critical for MzrA-EnvZ interactions and to reveal MzrA residues that play an important role in these interactions. Data obtained from chimeric constructs, in which the transmembrane domain of MzrA was replaced with the unrelated transmembrane domain of NarX or signal sequence of PhoA, showed that the transmembrane domain residues of MzrA do not play a critical role in MzrA-EnvZ interactions. The importance of the periplasmic domain of MzrA in MzrA-EnvZ interactions was revealed by characterizing bifunctional, fully soluble, and periplasmically localized MalE::MzrA chimeras. This was further corroborated through the isolation of loss-of-function, single-amino-acid substitutions in the conserved periplasmic domain of MzrA that interfered with MzrA-EnvZ binding in a bacterial two-hybrid system. Together, the data suggest that the binding of MzrA to EnvZ influences the ability of EnvZ to receive and/or respond to environmental signals in the periplasm and modulate its biochemical output to OmpR.

A single residue in transmembrane domain 11 defines the different affinity for thiazides between the mammalian and flounder NaCl transporters

Little is known about the residues that control the binding and affinity of thiazide-type diuretics for their protein target, the renal Na(+)-Cl(-) cotransporter (NCC). Previous studies from our group have shown that affinity for thiazides is higher in rat (rNCC) than in flounder (flNCC) and that the transmembrane region (TM) 8-12 contains the residues that produce this difference. Here, an alignment analysis of TM 8-12 revealed that there are only six nonconservative variations between flNCC and mammalian NCC. Two are located in TM9, three in TM11, and one in TM12. We used site-directed mutagenesis to generate rNCC containing flNCC residues, and thiazide affinity was assessed using Xenopus laevis oocytes. Wild-type or mutant NCC activity was measured using (22)Na(+) uptake in the presence of increasing concentrations of metolazone. Mutations in TM11 conferred rNCC an flNCC-like affinity, which was caused mostly by the substitution of a single residue, S575C. Supporting this observation, the substitution C576S conferred to flNCC an rNCC-like affinity. Interestingly, the S575C mutation also rendered rNCC more active. Substitution of S575 in rNCC for other residues, such as alanine, aspartate, and lysine, did not alter metolazone affinity, suggesting that reduced affinity in flNCC is due specifically to the presence of a cysteine. We conclude that the difference in metolazone affinity between rat and flounder NCC is caused mainly by a single residue and that this position in the protein is important for determining its functional properties.

The role of individual amino acids in the dimerization of CR4 and ACR4 transmembrane domains

CRINKLY4 is a growth factor-like plant receptor kinase designated as CR4 in Zea mays and ACR4 in Arabidopsis. Using the TOXCAT system, a genetic assay that measures helix interactions in a natural membrane environment, we have previously demonstrated that the dimerization potential of the ACR4 transmembrane (TM) domain is significantly weaker than that of CR4 TM domain, even though 13 of the 24 residues are identical. Neither of the TM domains contain the GxxxG motif that has been shown to be important for the dimerization of the TM segments of several receptors. To further investigate the relationship between protein sequence and dimerization potential, we (a) mutated each of the 11 differing residues in the CR4 TM domain to the corresponding residue of ACR4 (b) made reciprocal mutations in ACR4 and (c) made hybrids consisting of half CR4 and half ACR4 TM domains. Our results suggest that most mutations in ACR4 or CR4 TM domains have low to moderate effects on the dimerization potential and that residues in the N-terminal half of the CR4 TM domain are important for dimerization.

Role of Transmembrane Domain 4 in Ligand Permeation by Crithidia fasciculata Equilibrative Nucleoside Transporter 2 (CfNT2)

Equilibrative nucleoside transporters play essential roles in nutrient uptake, cardiovascular and renal function, and purine analog drug chemotherapies. Limited structural information is available for this family of transporters; however, residues in transmembrane domains 1, 2, 4, and 5 appear to be important for ligand and inhibitor binding. In order to identify regions of the transporter that are important for ligand specificity, a genetic selection for mutants of the inosine-guanosine-specific Crithidia fasciculata nucleoside transporter 2 (CfNT2) that had gained the ability to transport adenosine was carried out in the yeast Saccharomyces cerevisiae. Nearly all positive clones from the genetic selection carried mutations at lysine 155 in transmembrane domain 4, highlighting lysine 155 as a pivotal residue governing the ligand specificity of CfNT2. Mutation of lysine 155 to asparagine conferred affinity for adenosine on the mutant transporter at the expense of inosine and guanosine affinity due to weakened contacts to the purine ring of the ligand. Following systematic cysteine-scanning mutagenesis, thiol-specific modification of several positions within transmembrane domain 4 was found to interfere with inosine transport capability, indicating that this helix lines the water-filled ligand translocation channel. Additionally, the pattern of modification of transmembrane domain 4 suggested that it may deviate from helicity in the vicinity of residue 155. Position 155 was also protected from modification in the presence of ligand, suggesting that lysine 155 is in or near the ligand binding site. Transmembrane domain 4 and particularly lysine 155 appear to play key roles in ligand discrimination and translocation by CfNT2.

Activation Induces Structural Changes in the Liganded Angiotensin II Type 1 Receptor

The octapeptide hormone angiotensin II (AngII) binds to and activates the human angiotensin II type 1 receptor (hAT(1)) of the G protein-coupled receptor class A family. Several activation mechanisms have been proposed for this family, but they have not yet been experimentally validated. We previously used the methionine proximity assay to show that 11 residues in transmembrane domain (TMD) III, VI, and VII of the hAT(1) receptor reside in close proximity to the C-terminal residue of AngII. With the exception of a single change in TMD VI, the same contacts are present on N111G-hAT(1), a constitutively active mutant; this N111G-hAT(1) is a model for the active form of the receptor. In this study, two series of 53 individual methionine mutations were constructed in TMD I, II, IV, and V on both receptor forms. The mutants were photolabeled with a neutral antagonist, (125)I-[Sar(1),p-benzoyl-L-Phe(8)]AngII, and the resulting complexes were digested with cyanogen bromide. Although no new contacts were found for the hAT(1) mutants, two were found in the constitutively active mutants, Phe-77 in TMD II and Asn-200 in TMD V. To our knowledge, this is the first time that a direct ligand contact with TMD II and TMD V has been reported. These contact point differences were used to identify the structural changes between the WT-hAT(1) and N111G-hAT(1) complexes through homology-based modeling and restrained molecular dynamics. The model generated revealed an important structural rearrangement of several TMDs from the basal to the activated form in the WT-hAT(1) receptor.

Replacement of a single cysteine in the fourth transmembrane region of zebrafish pannexin1 alters hemichannel gating behavior

Pannexin1 (Panx1) is a novel candidate for an electrical synapse protein in the retina. At present Panx1 is considered to function as a hemichannel. Since information about the gating properties of Panx1 channels to date rely on blocker pharmacology, we have begun to establish a structural context of channel function starting with site directed mutagenesis of cysteine residues in transmembrane domains of Panx1. Dye uptake and whole cell voltage clamp recordings of transfected N2a cells demonstrate that zfPanx1 forms voltage activated hemichannels with a large unitary conductance in vitro. The function of this channel was significantly reduced following mutation of a single cysteine residue (C282W) in the fourth transmembrane region. This result suggests a role of this domain in gating of the Panx1 hemichannel.

Amino acid residues in transmembrane domain 1 and in the membrane proximal C‐tail of muscarinic M1receptors are necessary for transport‐competent folding

The principle goal of this investigation was to identify the functional role of a conserved C‐terminal tail motif, 423‐F(X)6LL‐431, in muscarinic M1 receptors. Point mutations were introduced into this motif, and at the base of transmembrane spanning domain 1 (TM1), using site‐directed mutagenesis. Wild‐type and mutant M1 receptors were transiently expressed in CHO cells and the amount of receptor expressed on the plasma membrane was determined using intact, whole cell [3H]‐N‐methylscopolamine ([3H]NMS) binding assays. Mutation of Leu pair 430‐LL‐431 in the F(X)6LL motif to an Ala pair (hM1LL430‐431) caused a 92% reduction in the plasma membrane expression of M1 receptors. Similarly, mutation of 46‐VL‐47 at the base of TM1 to 46‐AA‐47 (hM1VL46‐47) caused a 98% reduction in plasma membrane expression. The plasma membrane expression of hM1LL430‐431 and hM1VL46‐47 receptors increased 5.3‐ and 18.2‐fold, respectively, when incubated with atropine (0.1 μM) for 18 h. Unlike GFP‐tagged M1 receptors, GFP‐tagged M1LL430‐431 receptors colocalized extensively with the ER marker DsRed‐ER. When incubated with atropine (0.1 mM) for 18 h, GFP‐tagged M1LL430‐431 receptors acquired a cellular localization consistent with that of wild‐type receptors (i.e., expressed on the plasma membrane). Collectively, these data suggest that 430‐LL‐431 and 46‐VL‐47 are necessary for transport‐competent folding of M1 receptors.

Transmembrane Domain 8 of the γ-Aminobutyric Acid Transporter GAT-1 Lines a Cytoplasmic Accessibility Pathway into Its Binding Pocket

GAT-1 is a sodium- and chloride-coupled gamma-aminobutyric acid (GABA) transporter, which fulfills an essential role in the synaptic transmission by this neurotransmitter. Cysteine-399 is the major site of inhibition of GAT-1 by membrane-permeant sulfhydryl reagents. This cysteine residue was previously thought to reside on a cytoplasmic loop connecting transmembrane domains (TMs) 8 and 9. However, the crystal structure of LeuT, a bacterial homologue of the mammalian neurotransmitter:sodium symporters, revealed that the residue corresponding to Cys-399 is in fact located in the middle of TM 8. This residue is located to the cytoplasmic side of Asp-395 and Ser-396, whose side chains are thought to ligand one of the two cotransported sodium ions. To determine how the sulfhydryl reagents approach cysteine-399, a cysteine scan of all 35 residues of TM 8 was performed. Sulfhydryl reagents inhibited transport when a cysteine residue was present at either of the positions 399, 402, 406, and 410. SKF-89976A and other non-transportable analogues, which are expected to lock the transporter in a conformation facing the extracellular medium, protected against the sulfhydryl modification at positions 399, 402, and 406. Such a protection was not seen by GABA itself, which actually modestly potentiated the modification at positions 399 and 402. Our results point to an alpha-helical stripe on TM8 lining an aqueous access pathway from the cytoplasm into the binding pocket, which gets occluded in the conformation of the transporter where the binding pocket is exposed to the extracellular medium.